NCT05448365 Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid
| NCT ID | NCT05448365 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lo.Li.Pharma s.r.l |
| Condition | Uterine Fibroids |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-07-01 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-07-01 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6. The patients will be evaluated at baseline and after three months of treatment with placebo or product.
Eligibility Criteria
Inclusion Criteria: 1. uterine fibroid with diameter greater than or equal to 4cm or multiple fibroids 2. eligible for surgery 3. symptoms like menometrorrhagia or pelvic pain Exclusion Criteria: 1. BMI\>30 2. currently pregnant or breastfeeding 3. diabetic 4. suspect of malignancy 5. diagnosis of cancer
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05448365 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 40 Years, studying Uterine Fibroids. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05448365 currently recruiting?
Yes, NCT05448365 is actively recruiting participants. Contact the research team at mstomati@gmail.com for enrollment information.
Where is the NCT05448365 trial being conducted?
This trial is being conducted at Francavilla Fontana, Italy, Scorrano, Italy.
Who is sponsoring the NCT05448365 clinical trial?
NCT05448365 is sponsored by Lo.Li.Pharma s.r.l. The trial plans to enroll 60 participants.